Pharmaceutical Manufacturing Handbook: Production and

972 ROLE OF PREFORMULATION IN DEVELOPMENT OF SOLID DOSAGE FORMS
to discovering a new drug, a new drug delivery system can be designed at one - third
of the cost and money involved in a new drug discovery process [56] . The availability
of high - throughput property screens and predictive models is expected to
improve the effi ciency and maximize the output of preformulation data in the
coming years. However, the main challenge lies in intelligent use of such tools to
make sense from loads of data and communicate the appropriate information to
the relevant discovery/development groups for getting the drug to the marketplace
in time.
REFERENCES
1. Waterbeemd , H. V. , and Gifford , E. ( 2003 ), ADMET in silico modeling: Towards prediction
paradise , Nat. Rev. Drug Discov. , 2 , 192 – 204 .
2. Kerns , E. H. , and Di , L. ( 2003 ), Physicochemical profi ling in drug discovery , Drug Discov.
Today , 8 , 316 – 323 .
3. Lennarnas , H. , and Abrahamsson , B. ( 2005 ), The use of biopharmaceutical classifi cation
of drugs in drug discovery and development: Current status and future extensions ,
J. Pharm. Pharmacol. , 57 , 273 – 285 .
4. Lipinski , C. , Lombardo , F. , Dominy B. W. , and Feeney , P. J. ( 2001 ), Experimental and
computational approaches to estimate solubility and permeability in drug discovery and
development settings , Adv. Drug Deliv. Rev. , 46 , 3 – 26 .
5. Giron , D. ( 1998 ), Contribution of thermal methods and related techniques to the rational
development of pharmaceuticals. Part I , Pharm. Sci. Technol. Today , 1 , 191 – 199 .
6. Ahuja , S. ( 2007 ), Assuring quality of drugs by monitoring impurities , Adv. Drug Deliv.
Rev. , 59 , 3 – 11 .
7. Datta , S. , and Grant , D. J. W. ( 2004 ), Crystal structures of drugs: Advances in determination,
prediction and engineering , Nat. Rev. Drug Discov. , 42 , 42 – 57 .
8. Tiwary , A. K. ( 2004 ), Modifi cation of crystal habit and its role in dosage form performance
, Drug Dev. Ind. Pharm. , 27 , 699 – 707 .
9. Garekani , H. A. , Ford , J. L. , Rubinstein , M. H. , and Rajabi - Sahboomi , A. R. ( 1999 ), Formation
and compression characteristics of prismatic, polyhedral and thin plate - like crystals
of paracetamol , Int. J. Pharm. , 187 , 77 – 89 .
10. Gu , C. , Li , H. , Gandhi , R. B. , and Raghavan , K. ( 2004 ), Grouping solvents by statistical
analysis of solvent property parameters: Implication to polymorph screening , Int. J.
Pharm. , 283 , 117 – 125 .
11. Giron , D. ( 2001 ), Investigations of polymorphism and pseudopolymorphism in pharmaceuticals
by combined thermoanalytical techniques , J. Thermal Anal. Calor. , 64 , 37 –
60 .
12. Threafall , T. ( 2003 ), Structural and thermodynamic aspects of Ostwald ’ s rule , Org. Proc.
Res. Dev. , 7 , 1017 – 1027 .
13. Vippagunata , S. R. , Brittain , H. G. , and Grant , D. J. W. ( 2001 ), Crystalline solids , Adv. Drug
Deliv. Rev. , 48 , 3 – 26 .
14. Phadnis , N. V. , Cavatur , R. K. , and Suryanarayanan , R. ( 1997 ), Identifi cation of drugs in
pharmaceutical dosage forms by x - ray powder diffractometry , J. Pharm. Biomed. Anal. ,
15 , 929 – 943 .
15. Haleblain , J. , and McCrone , W. ( 1969 ), Pharmaceutical applications of polymorphism ,
J. Pharm. Sci. , 58 , 911 – 929 .